molecule.one | Latest News & Updates - Jan 10, 2025 Release
Marco Farinone has joined molecule.one as an Organic Chemist in Poland, previously working as a Scientist II at Ryvu Therapeutics...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
molecule.one
🌎 molecule.onemolecule.one is a pharmaceutical manufacturing company based in Warsaw, Mazowieckie, that utilizes artificial intelligence to design novel chemical syntheses rapidly, aiming to accelerate the development of medicines.
molecule.one - Latest News and Updates
- Marco Farinone has joined molecule.one as an Organic Chemist in Poland, previously working as a Scientist II at Ryvu Therapeutics.
- molecule.one is attending JPM 2025 to discuss collaboration opportunities in small-molecule drug development with services like virtual screens, large screening libraries, and reaction outcome prediction.
- Piotr Byrski, CEO of molecule.one, discussed expanding collaboration with Charles River Laboratories on the M1 RetroScore tool for drug discovery.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.